Frailty measurements may still provide helpful information in other ways, of course. 

Researchers examined data from the SYNTAX, PRECOMBAT, NOBLE and EXCEL trials, sharing their findings in The Lancet.

The blood-based biomarker was previously associated with worse acute coronary syndrome outcomes. What does it mean for TAVR patients?

Providers are struggling to address disparities in minority communities, the American Lung Association reported.  

It’s part of a suite of solutions from the Chicago-based technology giant, embedded in mobile imaging devices to improve quality. 

That according to a new large-scale analysis from Kaiser Permanente, published in JAMA Network Open.  

Additionally, 71% of medical professionals said safety standards increased during the health crisis.

“Cell therapy has the potential to change how we treat heart failure,” one researcher said.

The company reported that its deep neural network led to improved sensitivity and fewer unclassified findings. 

The move can help providers avoid prematurely attributing symptoms to a specific disease, the college said.